Principal Financial Group’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-191,578
| Closed | -$15.3M | – | 2691 |
|
|
2021
Q1 | $15.3M | Buy |
191,578
+21,564
| +13% | +$1.68M | 0.01% | 1139 |
|
|
2020
Q4 | $13.4M | Buy |
170,014
+7,107
| +4% | +$417K | 0.01% | 1055 |
|
|
2020
Q3 | $7.16M | Buy |
162,907
+19,609
| +14% | +$966K | 0.01% | 1273 |
|
|
2020
Q2 | $6.34M | Sell |
143,298
-343,236
| -71% | -$12.8M | 0.01% | 1323 |
|
|
2020
Q1 | $17.5M | Buy |
486,534
+78,667
| +19% | +$4.47M | 0.02% | 606 |
|
|
2019
Q4 | $28.9M | Buy |
407,867
+251,756
| +161% | +$18.3M | 0.02% | 586 |
|
|
2019
Q3 | $11.7M | Sell |
156,111
-1,106
| -0.7% | -$93.8K | 0.01% | 1122 |
|
|
2019
Q2 | $12.7M | Sell |
157,217
-4,655
| -3% | -$327K | 0.01% | 1092 |
|
|
2019
Q1 | $10.8M | Buy |
161,872
+1,018
| +0.6% | +$77.1K | 0.01% | 1181 |
|
|
2018
Q4 | $12M | Sell |
160,854
-3,317
| -2% | -$274K | 0.01% | 1064 |
|
|
2018
Q3 | $15.1M | Buy |
164,171
+5,196
| +3% | +$495K | 0.01% | 1059 |
|
|
2018
Q2 | $15.6M | Sell |
158,975
-5,628
| -3% | -$629K | 0.01% | 985 |
|
|
2018
Q1 | $18.3M | Sell |
164,603
-116,255
| -41% | -$13M | 0.02% | 846 |
|
|
2017
Q4 | $28.9M | Buy |
280,858
+6,631
| +2% | +$661K | 0.03% | 612 |
|
|
2017
Q3 | $25.8M | Sell |
274,227
-7,122
| -3% | -$562K | 0.03% | 636 |
|
|
2017
Q2 | $21.9M | Sell |
281,349
-11,730
| -4% | -$881K | 0.02% | 713 |
|
|
2017
Q1 | $23.5M | Buy |
293,079
+9,960
| +4% | +$792K | 0.03% | 631 |
|
|
2016
Q4 | $22.3M | Buy |
283,119
+11,055
| +4% | +$859K | 0.03% | 627 |
|
|
2016
Q3 | $21.2M | Buy |
272,064
+12,417
| +5% | +$901K | 0.03% | 619 |
|
|
2016
Q2 | $17.8M | Buy |
259,647
+6,971
| +3% | +$481K | 0.02% | 687 |
|
|
2016
Q1 | $18M | Buy |
252,676
+9,956
| +4% | +$625K | 0.03% | 634 |
|
|
2015
Q4 | $15.1M | Buy |
242,720
+10,052
| +4% | +$613K | 0.02% | 698 |
|
|
2015
Q3 | $13.2M | Buy |
232,668
+11,600
| +5% | +$614K | 0.02% | 758 |
|
|
2015
Q2 | $11.9M | Sell |
221,068
-3,823
| -2% | -$186K | 0.02% | 886 |
|
|
2015
Q1 | $10.7M | Buy |
224,891
+4,825
| +2% | +$214K | 0.02% | 927 |
|
|
2014
Q4 | $9.52M | Buy |
220,066
+1,549
| +0.7% | +$63.3K | 0.01% | 986 |
|
|
2014
Q3 | $7.51M | Buy |
218,517
+7,570
| +4% | +$267K | 0.01% | 1090 |
|
|
2014
Q2 | $7.72M | Sell |
210,947
-147,945
| -41% | -$5.02M | 0.01% | 1114 |
|
|
2014
Q1 | $12.1M | Buy |
358,892
+9,737
| +3% | +$321K | 0.02% | 782 |
|
|
2013
Q4 | $11.8M | Buy |
349,155
+14,370
| +4% | +$498K | 0.02% | 771 |
|
|
2013
Q3 | $10.7M | Sell |
334,785
-109,394
| -25% | -$2.91M | 0.02% | 773 |
|
|
2013
Q2 | $10M | Buy |
+444,179
| New | +$9.62M | 0.02% | 766 |
|
Principal Financial Group's CMD Position: Q2 2021 in Review
Principal Financial Group sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 191,578 shares — an estimated $15.3M sold.
Principal Financial Group first reported a position in CMD in Q2 2013 and held it in 32 quarters. The position peaked at $28.9M in Q4 2019. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Principal Financial Group reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Principal Financial Group sold 191,578 Cantel Medical Corporation shares in Q2 2021, an estimated $15.3M.
- Principal Financial Group first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 32 quarters.
- Principal Financial Group's Cantel Medical Corporation position peaked at $28.9M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Principal Financial Group's 13F filing for Q2 2021, filed 10 Aug 2021.